Sarah A. Richman, Ph.D.
Affiliations: | 2007 | University of Illinois, Urbana-Champaign, Urbana-Champaign, IL |
Area:
Molecular BiologyGoogle:
"Sarah Richman"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| David Michael Kranz | grad student | 2007 | UIUC | |
| (Engineering T cell receptors for potential therapeutic applications.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ghassemi S, Martinez-Becerra FJ, Master AM, et al. (2020) Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design. Molecular Therapy. Methods & Clinical Development. 18: 595-606 |
| Richman SA, Wang LC, Moon EK, et al. (2020) Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Richman SA, Wang LC, Khire UR, et al. (2020) Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Ghassemi S, Martinez-Becerra F, Master A, et al. (2020) Novel media formulations to enhance Chimeric Antigen Receptor (CAR) T-cell potency and anti-tumor cell function for adoptive immunotherapy Cytotherapy. 22: S133 |
| Sellmyer MA, Richman SA, Lohith K, et al. (2019) Imaging CAR T Cell Trafficking with eDFHR as a PET Reporter Gene. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Richman SA, Milone MC. (2018) Neurotoxicity Associated with a High-Affinity GD2 CAR-Response. Cancer Immunology Research. 6: 496-497 |
| Richman SA, Nunez-Cruz S, Moghimi B, et al. (2017) High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model. Cancer Immunology Research |
| Zuber J, Rosen S, Shonts B, et al. (2015) Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons |
| Schmitt TM, Aggen DH, Stromnes IM, et al. (2013) Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection. Blood. 122: 348-56 |
| Aggen DH, Chervin AS, Schmitt TM, et al. (2012) Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains. Gene Therapy. 19: 365-74 |